The American Society of Clinical Oncology (ASCO) Research Community Forum (RCF) is holding a free, two-part webinar on Food and Drug Administration (FDA) audit readiness, which will take participants on a journey through the FDA inspection process. These webinars will share practical strategies and best practices to help sites more effectively prepare for audits and follow-up post-inspection.
The first webinar, FDA Audit Readiness Part 1: Reflections from the FDA and a Principal Investigator, will take place February 13, 2020 from 2:00-3:00 p.m. ET. Yang-min (Max) Ning MD, MS, PhD, Senior Medical Officer and Medical Oncologist at the FDA, and James Reeves, MD, Director of Research Operations from Florida Cancer Specialists, will share case studies and lessons learned on site selection and the investigator role.
The second webinar, FDA Audit Readiness Part 2: Site Readiness using the ASCO FDA Audit Readiness Toolkit, will take place March 10, 2020 from 1:00-2:00 p.m. ET. During the webinar, Dr. Ning; Katie Goodman, RN, BSN, CCRP, Clinical Research Director of Florida Cancer Specialists; and Andrea Buchmeier, MHA, CCRC, LSSGB, Associate Regional Vice President of Cancer Services at Sarah Cannon will offer strategies for effective pre-audit preparation and post-audit follow-up. (Please note: you will need to complete a brief demographic survey for access to the Toolkit.)
ASCO’s RCF serves as a go-to resource for all members of the oncology research community, including physician investigators, research staff, and those involved in community-based and academic-based research programs. Join the ASCO RCF Online Forum to engage and network with colleagues, share best practices, and access resources (Please note: access to the online forum requires an asco.org account).
This activity is approved for American Medical Association Physician’s Recognition Awards Category 1 Credit™ and nursing continuing education credits.
Register today to attend the webinars.